Going the distance.

THAT’S OUR TARGET

By activating the immune system within the tumor, the road ahead for patients is paved with possibility.

Learn More

Transforming Immunity. Restoring Hope.

We’re devoted to redefining the treatment of cancer and rare diseases where serious unmet needs exist.

Learn More

Meaningful Treatments.

We’re committed to investigating new medicines that have the potential to improve lives.

Learn More

The Latest

Keep up with what’s happening at Idera Pharmaceuticals.

News

Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer

–   COO Role is Key to Preparedness for NDA Filing and Commercial Launch – –   Clayton… Read more 

Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

ILLUMINATE-301 Continues on Track and Beyond Melanoma Strategy Advances EXTON, Pa. , Oct. 29, 2020… Read more 

Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037

– Protects Method-of-Use in CRC and HNSCC – EXTON, Pa. , Sept. 28, 2020 (GLOBE NEWSWIRE) --… Read more 

Learn More